<PAGE>
As filed with the Securities and Exchange Commission on December 1, 2000.
Registration No. 333-37968
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
Post-Effective
Amendment No. 1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
IMPAX LABORATORIES, INC.
------------------------
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
30831 Huntwood Avenue
Delaware Hayward, California 94544 65-0403311
------------------------------- ------------------------- ------------------
<S> <C> <C>
(State or other jurisdiction of (Address of Principal (I.R.S. Employer
incorporation or organization) Executive Offices) Identification No.)
(Zip Code)
</TABLE>
IMPAX LABORATORIES, INC. 1999 EQUITY INCENTIVE PLAN
(Full title of the Plan)
Barry Edwards
Co-Chief Executive Officer
Impax Laboratories, Inc.
Castor & Kensington Avenue
Philadelphia, Pennsylvania 19124
Telephone (215) 289-2220
---------------------------------------------------------
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
Copies to:
Sol Genauer, Esq.
Blank Rome Comisky & McCauley LLP
One Logan Square
Philadelphia, Pennsylvania 19103
Telephone: (215) 569-5500
Facsimile: (215) 569-5555
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
================================================== ================= ================== ================== ==================
Proposed Proposed
maximum maximum Amount of
Title of securities Amount to be offering price aggregate registration
to be registered Registered (1) per share(2) offering price(2) fee
-------------------------------------------------- ----------------- ------------------ ------------------ ------------------
<S> <C> <C> <C> <C>
Common stock, par value $.01 per share......... 2,600,000 shares $5.91 $15,366,000 $4,056.62
-------------------------------------------------- ----------------- ------------------ ------------------ ------------------
</TABLE>
(1) The Impax Laboratories, Inc. 1999 Equity Incentive Plan was amended to
increase the number of shares of common stock authorized to be granted
under the plan from 2,400,000 to 5,000,000. The additional number of
shares, 2,600,000, are being registered by this amendment. This
registration statement also relates to an indeterminate number of
shares of common stock that may be issued upon stock splits, stock
dividends or similar transactions in accordance with Rule 416.
(2) The price is estimated in accordance with Rule 457(h)(1) under the
Securities Act of 1933, as amended, solely for the purpose of
calculating the registration fee, based on the average of the high and
low prices of the common stock as reported on the Nasdaq National
Market on November 28, 2000
================================================================================
<PAGE>
The contents of the Registration Statement on Form S-8 filed by Impax
Laboratories, Inc. on May 26, 2000, under SEC File No. 333-37968 is incorporated
by reference.
The purpose of this Amendment No. 1 is to increase the number of shares
of Common Stock registered in this Registration Statement on Form S-8 from
2,400,000 shares to 5,000,000 shares of Common Stock pursuant to an increase in
the number of shares of Common Stock available under Impax Laboratories, Inc.'s
1999 Equity Incentive Plan, which was approved by the shareholders of Impax
Laboratories, Inc. at a special meeting of the shareholders held on October 3,
2000.
Item 8. Exhibits.
The following exhibits are filed as part of this registration statement
or, where so indicated, have been previously filed and are incorporated hereby
by reference.
Number Description
------ -----------
5.1 Opinion of Blank Rome Comisky & McCauley LLP.
23.1 Consent of PricewaterhouseCoopers LLP.
23.2 Consent of Blank Rome Comisky & McCauley LLP
(included in Exhibit 5.1).
24.1 Power of Attorney (included on signature page).
II-1
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended,
the registrant certifies that it has reasonable grounds to believe that it meets
all the requirements for filing on Form S-8 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, on the date indicated.
IMPAX LABORATORIES, INC.
Date: November 29, 2000 By: /s/ Barry R. Edwards
-------------------------------------
Barry R. Edwards, Co-Chief Executive
Officer (Principal Executive Officer)
and Director
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Form S-8 registration statement has been signed by the following persons in
the capacities and on the dates indicated:
<TABLE>
<CAPTION>
Name Title Date
---- ----- ----
<S> <C> <C>
* Chairman, Co-Chief Executive Officer November __, 2000
--------------------------------- (Principal Executive Officer) and Director -----------------
Charles Hsiao, Ph.d
/s/ Barry R. Edwards Co-Chief Executive Officer and Director November 29, 2000
------------------------------- -----------------
Barry R. Edwards
* President, Chief Operating Officer and Director November __, 2000
--------------------------------- -----------------
Larry Hsu, Ph.d
* Chief Financial Officer (Principal Financial November __, 2000
--------------------------------- and Accounting Officer) -----------------
Cornel C. Spiegler
* Director November __, 2000
--------------------------------- -----------------
David J. Edwards
* Director November __, 2000
--------------------------------- -----------------
Brian Keng
* Director November __, 2000
--------------------------------- -----------------
Jason Lin
* Director November __, 2000
--------------------------------- -----------------
Michael Markbreiter
* Director November __, 2000
--------------------------------- -----------------
Oh Kim Sun
* Director November __, 2000
--------------------------------- -----------------
Nigel Fleming, Ph.d
* /s/ Barry R. Edwards November 29, 2000
----------------------- -----------------
Barry R. Edwards,
Attorney-in-Fact
</TABLE>
<PAGE>
Exhibit Index
Number Description
------ -----------
5.1 Opinion of Blank Rome Comisky & McCauley LLP.
10.1 Impax Laboratories, Inc. 1999 Equity Incentive Plan
23.1 Consent of PricewaterhouseCoopers LLP.
23.2 Consent of Blank Rome Comisky & McCauley LLP
(included in Exhibit 5.1).
24.1 Power of Attorney (included on signature page).
1
